When the EU’s Innovative Medicines Initiative launched the five-year EHDEN project in November 2018, it did so with an overarching goal in mind: to significantly improve patient treatment and care by unlocking the under-utilised and transformational potential of real world data. To this end, EHDEN began its journey to provide a new paradigm for the discovery and analysis of health data in Europe, by building a large-scale, federated network of data sources standardised to a common data model. More specifically, it set out to:
- Harmonise in excess of 100 million anonymised health records to the OMOP Common Data Model (CDM), supported by an ecosystem of certified SMEs (Small and Medium Sized Enterprises)
- Impact our understanding and improvement of clinical outcomes for patients in the many diverse healthcare systems within the EU
- Establish a self-sustaining open science collaboration in Europe to support academia, industry regulators, payers, government, NGOs and others
- Expand training and education by offering free, online courses via the EHDEN Academy
“EHDEN is a truly ground-breaking project that, in only a few years, is already providing a quantum leap for observational data research in Europe. The network of Data Partners and SMEs, together with the educational value of the EHDEN Academy, are creating an indispensable “fabric” that’s raising awareness, creating capacity, and hands-on training in health data standardisation and use, allowing for faster evidence-based decision making on matters that directly affect all citizens.” – CARLOS DÍAZ (CEO, Synapse Research Management Partners & SME, Spain)
Three years on, EHDEN has made significant headway, and has already eclipsed many of its targets, and this in the face of the COVID-19 pandemic, whereby travel restrictions limited face-to-face collaborations and working.
- Now working on harmonising ~500 million anoymised health records to the OMOP CDM, with 143 Data Partners in 27 countries after 5 open calls (Data Partner overview here)
- EHDEN has certified 47 SMEs in 27 countries after 3 open calls (Catalogue here)
- Evidence generation of ~40 publications, study-a-thons and use cases to date (more here)
- EHDEN Academy being used in >60 countries worldwide with ~1400 enrolled and ~1800 courses completed to date, with 14 courses online
- Ongoing development of the technical architecture of the project, in particularly the EHDEN Portal
- Great progress on methods and analytical tool development as well as use case progress across drug utilisation, safety, HTA and predictive analytics
- Setting up a new EHDEN not-for-profit legal entity to support in parallel longer term sustainability beyond the IMI phase (2024+)
Read more on the project first three years of progress and achievements here and attached, but below are some extracted quotes:
|
|
|
|